Pito Chickering
Stock Analyst at Deutsche Bank
(4.40)
# 1,176
Out of 4,457 analysts
367
Total ratings
60%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by Pito Chickering
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Maintained: Hold | $48 → $42 | $39.61 | +6.03% | 3 | May 7, 2026 | |
| DVA DaVita | Upgraded: Buy | $137 → $220 | $219.70 | +0.14% | 21 | May 5, 2026 | |
| BTSG BrightSpring Health Services | Maintained: Buy | $50 → $60 | $68.98 | -13.02% | 7 | May 4, 2026 | |
| ACHC Acadia Healthcare Company | Maintained: Buy | $26 → $32 | $27.69 | +15.57% | 24 | May 1, 2026 | |
| OPCH Option Care Health | Maintained: Buy | $38 → $26 | $21.29 | +22.15% | 17 | May 1, 2026 | |
| SYK Stryker | Maintained: Hold | $402 → $315 | $330.52 | -4.70% | 19 | May 1, 2026 | |
| BLCO Bausch + Lomb | Maintained: Hold | $18 → $16 | $16.63 | -3.79% | 7 | Apr 30, 2026 | |
| MMED MiniMed Group | Initiated Coverage: Buy | $20 | $14.88 | +34.41% | 1 | Mar 31, 2026 | |
| AHCO AdaptHealth | Maintained: Hold | $9.5 | $10.21 | -6.95% | 18 | Feb 25, 2026 | |
| MD Pediatrix Medical Group | Maintained: Hold | $15 → $19 | $24.63 | -22.86% | 19 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $42 → $20 | $22.02 | -9.17% | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $11.50 | +91.39% | 1 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $12 | $8.66 | +32.79% | 11 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $94 | $91.18 | +3.09% | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $136 → $178 | $212.64 | -16.29% | 14 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.85 | $0.5161 | n/a | 8 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $220 → $248 | $279.58 | n/a | 13 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $115 → $107 | $91.24 | n/a | 17 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $78 → $108 | $43.48 | n/a | 17 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $26 → $18 | $0.015 | n/a | 13 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $241 | $315.46 | n/a | 12 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $208 → $240 | $147.02 | n/a | 16 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $441 | $392.33 | n/a | 20 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $79 → $85 | $80.93 | n/a | 21 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $83 → $95 | $100.90 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $155 | $187.17 | n/a | 17 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $62 | $25.20 | n/a | 1 | Apr 19, 2021 |
Medline
May 7, 2026
Maintained: Hold
Price Target: $48 → $42
Current: $39.61
Upside: +6.03%
DaVita
May 5, 2026
Upgraded: Buy
Price Target: $137 → $220
Current: $219.70
Upside: +0.14%
BrightSpring Health Services
May 4, 2026
Maintained: Buy
Price Target: $50 → $60
Current: $68.98
Upside: -13.02%
Acadia Healthcare Company
May 1, 2026
Maintained: Buy
Price Target: $26 → $32
Current: $27.69
Upside: +15.57%
Option Care Health
May 1, 2026
Maintained: Buy
Price Target: $38 → $26
Current: $21.29
Upside: +22.15%
Stryker
May 1, 2026
Maintained: Hold
Price Target: $402 → $315
Current: $330.52
Upside: -4.70%
Bausch + Lomb
Apr 30, 2026
Maintained: Hold
Price Target: $18 → $16
Current: $16.63
Upside: -3.79%
MiniMed Group
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $14.88
Upside: +34.41%
AdaptHealth
Feb 25, 2026
Maintained: Hold
Price Target: $9.5
Current: $10.21
Upside: -6.95%
Pediatrix Medical Group
Feb 20, 2026
Maintained: Hold
Price Target: $15 → $19
Current: $24.63
Upside: -22.86%
Feb 13, 2026
Maintained: Hold
Price Target: $42 → $20
Current: $22.02
Upside: -9.17%
Jan 5, 2026
Initiated Coverage: Buy
Price Target: $22
Current: $11.50
Upside: +91.39%
Sep 15, 2025
Maintained: Buy
Price Target: $7 → $12
Current: $8.66
Upside: +32.79%
Jul 25, 2025
Maintained: Buy
Price Target: $85 → $94
Current: $91.18
Upside: +3.09%
Jul 23, 2025
Maintained: Hold
Price Target: $136 → $178
Current: $212.64
Upside: -16.29%
Feb 28, 2025
Downgraded: Hold
Price Target: $5 → $2.85
Current: $0.5161
Upside: n/a
Feb 7, 2025
Maintained: Hold
Price Target: $220 → $248
Current: $279.58
Upside: n/a
Feb 7, 2025
Maintained: Hold
Price Target: $115 → $107
Current: $91.24
Upside: n/a
Jan 10, 2025
Upgraded: Buy
Price Target: $78 → $108
Current: $43.48
Upside: n/a
Nov 8, 2024
Rated: Hold
Price Target: $26 → $18
Current: $0.015
Upside: n/a
Oct 31, 2024
Maintained: Buy
Price Target: $205 → $241
Current: $315.46
Upside: n/a
Oct 28, 2024
Reiterated: Buy
Price Target: $208 → $240
Current: $147.02
Upside: n/a
Oct 8, 2024
Maintained: Buy
Price Target: $441
Current: $392.33
Upside: n/a
Aug 20, 2024
Reiterated: Hold
Price Target: $79 → $85
Current: $80.93
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $83 → $95
Current: $100.90
Upside: n/a
Jul 24, 2024
Rated: Buy
Price Target: $155
Current: $187.17
Upside: n/a
Apr 19, 2021
Maintained: Hold
Price Target: $62
Current: $25.20
Upside: n/a